Authors:
VANLANGEVELDE P
KWAPPENBERG KMC
GROENEVELD PHP
MATTIE H
VANDISSEL JT
Citation: P. Vanlangevelde et al., ANTIBIOTIC-INDUCED LIPOPOLYSACCHARIDE (LPS) RELEASE FROM SALMONELLA-TYPHI - DELAY BETWEEN KILLING BY CEFTAZIDIME AND IMIPENEM AND RELEASE OF LPS, Antimicrobial agents and chemotherapy, 42(4), 1998, pp. 739-743
Citation: Aa. Firsov et H. Mattie, RELATIONSHIPS BETWEEN ANTIMICROBIAL EFFECT AND AREA UNDER THE CONCENTRATION-TIME CURVE AS A BASIS FOR COMPARISON OF MODES OF ANTIBIOTIC ADMINISTRATION - MEROPENEM BOLUS INJECTIONS VERSUS CONTINUOUS INFUSIONS, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 352-356
Authors:
MATTIE H
ZHANG LC
VANSTRIJEN E
SEKH BR
DOUWESIDEMA AEA
Citation: H. Mattie et al., PHARMACOKINETIC AND PHARMACODYNAMIC MODELS OF THE ANTISTAPHYLOCOCCAL EFFECTS OF MEROPENEM AND CLOXACILLIN IN-VITRO AND IN EXPERIMENTAL-INFECTION, Antimicrobial agents and chemotherapy, 41(10), 1997, pp. 2083-2088
Authors:
KLOPPENBURG M
MATTIE H
DOUWES N
DIJKMANS BAC
Citation: M. Kloppenburg et al., CONCENTRATION-EFFECT STUDIES - MAKING SENSE OF SPARSE CONCENTRATION -REPLY, Journal of rheumatology, 23(5), 1996, pp. 949-950
Authors:
KLOPPENBURG M
MATTIE H
DOUWES N
DIJKMANS BAC
BREEDVELD FC
Citation: M. Kloppenburg et al., MINOCYCLINE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS - RELATIONSHIP OF SERUM CONCENTRATIONS TO EFFICACY, Journal of rheumatology, 22(4), 1995, pp. 611-616
Authors:
VANDENBORNE BEEM
LANDEWE RBM
THE HSG
MATTIE H
BREEDVELD FC
DIJKMANS BAC
Citation: Beem. Vandenborne et al., RELATIVE BIOAVAILABILITY OF A NEW ORAL FORM OF CYCLOSPORINE-A IN PATIENTS WITH RHEUMATOID-ARTHRITIS, British journal of clinical pharmacology, 39(2), 1995, pp. 172-175
Authors:
MATTIE H
KUNST MW
SCHIEVINK HI
JONKER PL
DEJONGE P
Citation: H. Mattie et al., A MULTICENTER, RANDOMIZED COMPARATIVE-STUDY OF 500 MG VERSUS 1,000 MGCEFTAZIDIME TDS FOR TREATMENT OF GRAM-NEGATIVE INFECTIONS, Infection, 23(4), 1995, pp. 222-226
Citation: R. Bohte et al., LEVELS OF AZITHROMYCIN AND ALPHA-1-ACID GLYCOPROTEIN IN SERUM IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA, Antimicrobial agents and chemotherapy, 39(12), 1995, pp. 2801-2802
Citation: Ca. Verhagen et al., THE RENAL CLEARANCE OF CEFUROXIME AND CEFTAZIDIME AND THE EFFECT OF PROBENECID ON THEIR TUBULAR EXCRETION, British journal of clinical pharmacology, 37(2), 1994, pp. 193-197
Authors:
WERRE PF
MATTIE H
FORTGENS C
BERRETTY EW
SLUITER W
Citation: Pf. Werre et al., INTERACTION BETWEEN EXTROVERSION AND DRUG-INDUCED CONDITIONS AS INDICATED BY THE CONTINGENT NEGATIVE-VARIATION, Biological psychology, 39(1), 1994, pp. 45-56
Authors:
CALAME W
DOUWESIDEMA AE
VANDENBARSELAAR MT
VANFURTH R
MATTIE H
Citation: W. Calame et al., INFLUENCE OF CYTOSTATIC AGENTS ON THE PULMONARY DEFENSE OF MICE INFECTED WITH KLEBSIELLA-PNEUMONIAE AND ON THE EFFICACY OF TREATMENT WITH CEFTRIAXONE, The Journal of infection, 29(1), 1994, pp. 53-66
Citation: H. Mattie, THE IMPORTANCE OF PHARMACOKINETICS AND PHARMACODYNAMICS FOR EFFECTIVETREATMENT OF INFECTIONS, The Clinical investigator, 71(6), 1993, pp. 480-482
Authors:
SCHIEVINK HI
MATTIE H
THOMEER RTWM
VANSTRIJEN E
Citation: Hi. Schievink et al., THE PASSAGE OF CLOXACILLIN INTO CEREBROSPINAL-FLUID IN THE ABSENCE OFMENINGITIS, British journal of clinical pharmacology, 36(1), 1993, pp. 57-60
Authors:
MEYER AP
BRILBAZUIN C
MATTIE H
VANDENBROEK PJ
Citation: Ap. Meyer et al., UPTAKE OF AZITHROMYCIN BY HUMAN MONOCYTES AND ENHANCED INTRACELLULAR ANTIBACTERIAL ACTIVITY AGAINST STAPHYLOCOCCUS-AUREUS, Antimicrobial agents and chemotherapy, 37(11), 1993, pp. 2318-2322